Viewing Study NCT03097094


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-30 @ 3:13 PM
Study NCT ID: NCT03097094
Status: COMPLETED
Last Update Posted: 2022-11-15
First Post: 2017-03-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Precision Allergy: Separate Allergies to Male and Female Dogs
Sponsor: Copenhagen Studies on Asthma in Childhood
Organization:

Study Overview

Official Title: Precision Allergy: Separate Allergies to Male and Female Dogs
Status: COMPLETED
Status Verified Date: 2022-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A new male-specific dog-allergen-component has been found (Can f 5) which indicates possible differences in allergic reactions to male and female dogs. This has not yet been tested in real life.

The aim is to test if sensitization only to the male-dog specific allergen-component, Can f 5, results in a positive skin prick test (SPT) to male dog extract and not female dog extract. In addition, the investigators want to investigate if allergic symptoms only occur when exposed to the male dog extract by conjunctival provocation.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: